Stock & Company Details
Cognition Therapeutics Inc $CGTX
Price:
N/A
N/A
95M
$101M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.96
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CGTX technical indicators
Latest Cognition Therapeutics Inc (CGTX) indicator readings as of 2026-08-28.
CGTX's 14-day RSI is 50.1, in neutral territory. At $1.02 it is trading 15.5% below its 200-day moving average of $1.21, and below its 50-day average of $1.05. Price sits in the middle of its Bollinger Bands ($0.92 to $1.12). ADX reads 12.5, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Finance Bot
Ask your questions
Start by typing a question below.
